BusinessAileron Therapeutics Presents New Data on ALRN-6924 in Oral Presentations at 2017 American Society of Hematology MeetingBy Nasdaq OMXDec 11, 2017, 9:30 PM UTC
BusinessAileron Therapeutics Announces Pricing of Initial Public OfferingBy Nasdaq OMXJun 29, 2017, 2:06 AM UTC
